How does TCR-T cell therapy exhibit a superior anti-tumor efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How does TCR-T cell therapy exhibit a superior anti-tumor efficacy

Published:2023-12 Issue: Volume:687 Page:149209
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Yang Dandan,Duan Zhihui,Yuan Ping,Ding Chengming,Dai Xiaoming,Chen Guodong,Wu Daichao^ORCID

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference157 articles.

1. Virus-driven carcinogenesis;Hatano;Cancers,2021

2. Type I interferon-mediated tumor immunity and its role in immunotherapy;Yu;Cell. Mol. Life Sci.,2022

3. Engineering IL-2 for immunotherapy of autoimmunity and cancer;Hernandez;Nat. Rev. Immunol.,2022

4. Expression of PD1/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment;Wang;J. Cancer,2021

5. Roles of PD-1/PD-L1 pathway: signaling, cancer, and beyond;Ai;Adv. Exp. Med. Biol.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends;Biomarker Research;2024-08-31

2. CD8+ T cell-based cancer immunotherapy;Journal of Translational Medicine;2024-04-29

3. The recent advancement of TCR-T cell therapies for cancer treatment;Acta Biochimica et Biophysica Sinica;2024-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP